The drugs commonly used to treat bipolar disorder have limited efficacy and drug discovery is hampered by the paucity of knowledge of the pathophysiology of this disease. This study aims to explore the role of microRNAs in bipolar disorder and understand the molecular mechanisms of action of commonly used bipolar disorder drugs.
Methods:
The transcriptional effects of bipolar disorder drug combination (lithium, valproate, lamotrigine and quetiapine) in cultured human neuronal cells were studied using next generation sequencing. Differential expression of genes (n=20) and microRNAs (n=6) was assessed and the differentially expressed microRNAs were confirmed with TaqMan MicroRNA Assays. The expression of the differentially expressed microRNAs were inhibited to determine bipolar disorder drug effects on their target genes (n=8). Independent samples t-test was used for normally distributed data and Kruskal-Wallis/Mann-Whitney U test was used for data not distributed normally. Significance levels were set at p<0.05.
Results:
We found that bipolar disorder drugs tended to increase the expression of miR-128 and miR-378 (p<0.05). Putative target genes of these microRNAs targeted pathways including those identified as “neuron projection development” and “axonogenesis”. Many of the target genes are inhibitors of neurite outgrowth and neurogenesis and were downregulated following bipolar disorder drug combination treatment (all p<0.05). The bipolar disorder drug combination tended to decrease the expression of the target genes (NOVA1, GRIN3A, and VIM), however this effect could be reversed by the application of microRNA inhibitors.
Conclusions:
We conclude that at a transcriptional level, bipolar disorder drugs affect several genes in concert that would increase neurite outgrowth and neurogenesis and hence neural plasticity, and that this effect is mediated (at least in part) by modulation of the expression of these two key microRNAs.
BaldessariniRHenkHSklarA, et al. (2008) Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and adherence. Psychiatr Serv59: 1175–1183.
2.
BaliNArimotoJMMorganTE, et al. (2013) Progesterone antagonism of neurite outgrowth depends on microglial activation via Pgrmc1/S2R. Endocrinology154: 2468–2480.
3.
BartelDP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell116: 281–297.
4.
BerkMPostRRatheeshA, et al. (2017) Staging in bipolar disorder: From theoretical framework to clinical utility. World Psychiatry16: 236–244.
5.
Bocchio-ChiavettoLMaffiolettiEBettinsoliP, et al. (2013) Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol23: 602–611.
6.
BrunoIGKaramRHuangL, et al. (2011) Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell42: 500–510.
7.
CamkurtMAKarababaİFErdalME, et al. (2020) MicroRNA dysregulation in manic and euthymic patients with bipolar disorder. J Affect Disord261: 84–90.
8.
ChaoY-LChenC-H (2013) An introduction to microRNAs and their dysregulation in psychiatric disorders. Tzu Chi Med J25: 1–7.
9.
ChenHWangNBurmeisterM, et al. (2009) MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol12: 975–981.
10.
ChingA-SAhmad-AnnuarA (2015) A perspective on the role of microRNA-128 regulation in mental and behavioral disorders. Front Cell Neurosci9: 465.
11.
ChiuC-TWangZHunsbergerJG, et al. (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: Beyond bipolar disorder. Pharmacol Rev65: 105–142.
12.
De SmaeleEFerrettiEGulinoA (2010) MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res1338: 100–111.
13.
DengZDuWWFangL, et al. (2013) The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor. J Biol Chem288: 319–331.
14.
DwivediY (2014) Emerging role of microRNAs in major depressive disorder: Diagnosis and therapeutic implications. Dialogues Clin Neurosci16: 43–61.
15.
FranzoniEBookerSAParthasarathyS, et al. (2015) miR-128 regulates neuronal migration, outgrowth and intrinsic excitability via the intellectual disability gene Phf6. Elife4: e04263.
16.
GeddesJRMiklowitzDJ (2013) Treatment of bipolar disorder. Lancet381: 1672–1682.
17.
GrandeIBerkMBirmaherB, et al. (2016) Bipolar disorder. Lancet387: 1561–1572.
18.
Huang DaWShermanBTLempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc4: 44–57.
19.
HunsbergerJGChibaneFLElkahlounAG, et al. (2015) Novel integrative genomic tool for interrogating lithium response in bipolar disorder. Transl Psychiatry5: e504.
20.
JannMW (2014) Diagnosis and treatment of bipolar disorders in adults: A review of the evidence on pharmacologic treatments. Am Health Drug Benefits7: 489–499.
21.
KehoeLABelloneCDe RooM, et al. (2014) GluN3A promotes dendritic spine pruning and destabilization during postnatal development. J Neurosci34: 9213–9221.
22.
KhoutorskyAYanagiyaAGkogkasCG, et al. (2013) Control of synaptic plasticity and memory via suppression of poly(A)-binding protein. Neuron78: 298–311.
23.
KidnapillaiSBortolasciCCUdawelaM, et al. (2018) The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder. World J Biol Psychiatry1–9.
24.
KimAHReimersMMaherB, et al. (2010) MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res124: 183–191.
25.
KimDPerteaGTrapnellC, et al. (2013) TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol14: R36.
26.
KrichevskyAMKingKSDonahueCP, et al. (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA9: 1274–1281.
27.
KristBFlorczykUPietraszek-GremplewiczK, et al. (2015) The role of miR-378a in metabolism, angiogenesis, and muscle biology. Int J Endocrinol2015: 281756.
28.
LiYLiYMcKayRM, et al. (2012) Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants. J Neurosci32: 3529–3539.
29.
LipsteinNSchaksSDimovaK, et al. (2012) Nonconserved Ca(2+)/calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity. Mol Cell Biol32: 4628–4641.
30.
LiuSYZhangYYGaoY, et al. (2015) MiR-378 plays an important role in the differentiation of bovine preadipocytes. Cell Physiol Biochem36: 1552–1562.
31.
Machado-VieiraRManjiHKZarateCAJr. (2009) The role of lithium in the treatment of bipolar disorder: Convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord11(Suppl 2): 92–109.
32.
MaffiolettiECattaneoARossoG, et al. (2016) Peripheral whole blood microRNA alterations in major depression and bipolar disorder. J Affect Disord200: 250–258.
33.
MaffiolettiETarditoDGennarelliM, et al. (2014) Micro spies from the brain to the periphery: New clues from studies on microRNAs in neuropsychiatric disorders. Front Cell Neurosci8: 75.
34.
MaleticVRaisonC (2014) Integrated neurobiology of bipolar disorder. Front Psychiatry5: 98.
35.
McSweeneyKMGussowABBradrickSS, et al. (2016) Inhibition of microRNA 128 promotes excitability of cultured cortical neuronal networks. Genome Res26: 1411–1416.
36.
MeganathanKJagtapSSrinivasanSP, et al. (2015) Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells. Cell Death Dis6: e1756.
37.
MerikangasKRJinRHeJP, et al. (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry68: 241–251.
38.
MorimotoTWangXHPooMM (1998) Overexpression of synaptotagmin modulates short-term synaptic plasticity at developing neuromuscular junctions. Neuroscience82: 969–978.
39.
OhnoKKatoHFunahashiS, et al. (2009) Characterization of CLP36/Elfin/PDLIM1 in the nervous system. J Neurochem111: 790–800.
40.
PerkinsDOJeffriesCDJarskogLF, et al. (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol8: R27.
41.
PleasureSJPageCLeeVM (1992) Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci12: 1802–1815.
42.
RajkowskaG. (2002) Cell pathology in bipolar disorder. Bipolar Disord4: 105–116.
43.
RobinsonMDMcCarthyDJSmythGK (2010) edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics26: 139–140.
44.
RognerUCSpyropoulosDDLe NovereN, et al. (2000) Control of neurulation by the nucleosome assembly protein-1-like 2. Nat Genet25: 431–435.
45.
SachsGSPetersATSylviaL, et al. (2014) Polypharmacy and bipolar disorder: What’s personality got to do with it?Int J Neuropsychopharmacol17: 1053–1061.
46.
SáezJEGómezAVBarriosÁP, et al. (2015) Decreased expression of CoREST1 and CoREST2 together with LSD1 and HDAC1/2 during neuronal differentiation. PLoS One10: e0131760.
47.
SaitoYMiranda-RottmannSRuggiuM, et al. (2016) NOVA2-mediated RNA regulation is required for axonal pathfinding during development. Elife5: e14371.
48.
SchlagerMAKapiteinLCGrigorievI, et al. (2010) Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J29: 1637–1651.
49.
SempereLFFreemantleSPitha-RoweI, et al. (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol5: R13.
50.
ShimaYKawaguchiSYKosakaK, et al. (2007) Opposing roles in neurite growth control by two seven-pass transmembrane cadherins. Nat Neurosci10: 963–969.
51.
SmalheiserNRLugliGZhangH, et al. (2014) Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One9: e86469.
52.
TüfekciKUMeuwissenRLJGençŞ (2014) The role of microRNAs in biological processes. In: YousefMAllmerJ (eds) miRNomics: MicroRNA Biology and Computational Analysis. Totowa, NJ: Humana Press, pp. 15–31.
WyattLAFilbinMTKeirsteadHS (2014) PTEN inhibition enhances neurite outgrowth in human embryonic stem cell-derived neuronal progenitor cells. J Comp Neurol522: 2741–2755.
55.
YapCCLasieckaZMCaplanS, et al. (2010) Alterations of EHD1/EHD4 protein levels interfere with L1/NgCAM endocytosis in neurons and disrupt axonal targeting. J Neurosci30: 6646–6657.
56.
YathamLNKennedySHParikhSV, et al. (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders20: 97–170.
57.
YueYWidmerDAHalladayAK, et al. (1999) Specification of distinct dopaminergic neural pathways: Roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci19: 2090–2101.
58.
ZhangWKimPJChenZ, et al. (2016) MiRNA-128 regulates the proliferation and neurogenesis of neural precursors by targeting PCM1 in the developing cortex. Elife5: e11324.
59.
ZhouRYuanPWangY, et al. (2009) Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology34: 1395–1405.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
